Clinical Trials : Neoplasms, Cystic, Mucinous, and Serous


Completed	: Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms : Neoplasms, Cystic, Mucinous, and Serous : 2013-09-30 : Drug: Ethanol EUS-guided lavag
Withdrawn	: Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms : Neoplasms, Cystic, Mucinous, and Serous Pancreatic Neoplasms : 2010-01-26 : Procedure: EUS and/or ERCP with ethanol injections of pancreatic cyst Lavage of cyst with 80% ethanol
Recruiting	: Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor : Pancreatic Tumor Endocrine Tumor Neo : 2014-12-20 : Procedure: Radiofrequency Ablation under EUS Pancreatic radiofrequency ablation under endoscopic ultraso
Active, not recruiting	: Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial : Adenocarcinoma Rectal Diseases Colorectal Neoplasms < : 2013-11-21
Active, not recruiting	: Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks : Adenocarcinoma of the Rectum Adenocarcinoma Adenocarcinoma : 2009-12-18 : Other: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
Completed	: Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer : Endometrial Adenocarcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Adenocarcinoma Endometrial Clear Cell Adenocarcinoma Drug: Brivanib Alaninate Given